alka-seltzer effervescent tablets acetylsalicylic acid (aspirin) 324mg sodium hydrogen carbonate 1744mg citric acid 965mg
bayer limited - sodium hydrogen carbonate; aspirin; citric acid anhydrous - effervescent tablet - 324 mg/1744 mg/965 milligram(s) - salicylic acid and derivatives; acetylsalicylic acid
alka-seltzer effervescent tablets;acetylsalicylic acid (aspirin);sodium hyd carbonate;citric acid
bayer limited 1st floor the grange offices the grange brewery road stillorgan co. dublin, a94 h2k7 , ireland - citric acid, acetylsalicylic acid, sodium hydrogen, carbonate - effervescent tablet - acetylsalicylic acid 324 mg citric acid 965 mg sodium hydrogen carbonate 1744 mg - analgesics
clopidogrel/acetylsalicylic acid teva
teva pharma b.v. - clopidogrel, acetylsalicylic acid - acute coronary syndrome; myocardial infarction - combinations - clopidogrel/acetylsalicylic acid teva is indicated for the prevention of atherothrombotic events in adult patients already taking both clopidogrel and acetylsalicylic acid (asa). clopidogrel/acetylsalicylic acid teva is a fixed‑dose combination medicinal product for continuation of therapy in:non‑st segment elevation acute coronary syndrome (unstable angina or non‑q‑wave myocardial infarction) including patients undergoing a stent placement following percutaneous coronary interventionst segment elevation acute myocardial infarction in medically treated patients eligible for thrombolytic therapy
alka-seltzer
bayer bitterfeld gmbh - acetylsalicylic acid, citric acid, sodium bicarbonate - tablets effervescent - 324mg+965mg+1625mg
baythrom 324 milligram tablets
bayer plc - acetylsalicylic acid citric acid sodium bicarbonate - tablets - 324 milligram
clopidogrel / acetylsalicylic acid mylan
mylan pharmaceuticals limited - acetylsalicylic acid, clopidogrel hydrogen sulfate - acute coronary syndrome; myocardial infarction - antithrombotic agents - clopidogrel/acetylsalicylic acid mylan is indicated for the secondary prevention of atherothrombotic events in adult patients already taking both clopidogrel and acetylsalicylic acid (asa).clopidogrel/acetylsalicylic acid mylan is a fixed-dose combination medicinal product for continuation of therapy in:non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction) including patients undergoing a stent placement following percutaneous coronary interventionst segment elevation acute myocardial infarction in medically treated patients eligible for thrombolytic therapy
sodium bicarbonate injection bp minijet 8.4% w/v, solution for injection
international medication systems (uk) ltd - sodium bicarbonate - solution for injection - 8.4 percent weight/volume - electrolyte solutions; sodium bicarbonate
sodium bicarbonate injection bp minijet 8.4% w/v, solution for injection
dlrc pharma services limited - sodium bicarbonate - solution for injection - 8.4 percent weight/volume - electrolyte solutions; sodium bicarbonate
alka-seltzer tablet (effervescent)
bayer inc - acetylsalicylic acid; citric acid; sodium bicarbonate - tablet (effervescent) - 325mg; 1000mg; 1916mg - acetylsalicylic acid 325mg; citric acid 1000mg; sodium bicarbonate 1916mg - salicylates
sodium bicarbonate 8.4%
lapidot medical import and marketing ltd - sodium bicarbonate - solution for infusion - sodium bicarbonate 8.4 %w/v - salt solutions - metabolic acidosis, urine alkalization.